Most children are asymptomatic or exhibit mild symptoms from COVID-19 infection. However, a small number have been identified who develop a significant systemic inflammatory response, which is also known as PIMS-TS or PIMS). This document for clinicians, which has been developed after expert review of the cases, includes a case definition and approach to clinical management.
September 2020 update
In September 2020, A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS) was published